425380-39-8 Usage
General Description
1H-Pyrrolo[3,2-b]pyridine,7-methoxy-(9CI) is a complex organic compound that belongs to the class of organic compounds known as pyrrolopyridines. These are organic compounds containing a pyrrole ring (a five-membered aromatic ring with a nitrogen atom) fused to a pyridine ring (a six-membered aromatic heterocycle compound containing one nitrogen atom). The '7-methoxy' attribute indicates that a methoxy group (-OCH3) is attached to the 7th position of this combined ring structure. Due to its complex structure, this chemical might be used in medicinal chemistry or material science research, although specific data on its applications are sparse.
Check Digit Verification of cas no
The CAS Registry Mumber 425380-39-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,5,3,8 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 425380-39:
(8*4)+(7*2)+(6*5)+(5*3)+(4*8)+(3*0)+(2*3)+(1*9)=138
138 % 10 = 8
So 425380-39-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O/c1-11-7-3-5-9-6-2-4-10-8(6)7/h2-5,9H,1H3
425380-39-8Relevant articles and documents
CONDENSED HETEROCYCLIC COMPOUND
-
Paragraph 0372, (2019/03/13)
Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein.].
4-AZAINDOLE DERIVATIVES
-
Page/Page column 53; 54; 55, (2015/04/22)
4-Azaindole derivatives which are modulators of muscarinic acetylcholine receptor (mAChR) M1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as Alzheimer-type dementia (AD) or dementia with Lewy bodies (DLB), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient.
3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
-
Page/Page column 140-141, (2009/04/25)
The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein Q, R1, R4, m and Ar are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
